These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Transfusion medicine in near future]. Sekiguchi S Rinsho Byori; 1992 Jun; 40(6):617-25. PubMed ID: 1513033 [No Abstract] [Full Text] [Related]
6. [Posttransfusion graft vs host disease]. Muñoz MC; Hernández M; Rifón J; Panizo C; Rodríguez M Sangre (Barc); 1998 Feb; 43(1):55-8. PubMed ID: 9580428 [No Abstract] [Full Text] [Related]
7. [Management of pancytopenia blood component transfusion and recombinant growth factor]. Watanabe K; Yonekura S; Komatsuda M; Yabe M Nihon Rinsho; 1990 Sep; 48(9):2035-40. PubMed ID: 2172589 [No Abstract] [Full Text] [Related]
8. [The new Blood Law and new principles of transfusion therapy]. Takahashi K Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):3-6. PubMed ID: 15696691 [TBL] [Abstract][Full Text] [Related]
9. [Past, present, future use of blood substitutes and plasma substitutes in Japan]. Toyama H Masui; 1985 Apr; 34(4):515-29. PubMed ID: 4021100 [No Abstract] [Full Text] [Related]
11. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force. Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462 [No Abstract] [Full Text] [Related]
12. The use of leukocyte-reduced blood components. Miller JP; Mintz PD Hematol Oncol Clin North Am; 1995 Feb; 9(1):69-90. PubMed ID: 7737945 [TBL] [Abstract][Full Text] [Related]
13. [Current status and prospects for blood transfusion and products of blood components in the field of surgery]. Tsurumaru M Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):2. PubMed ID: 15696690 [No Abstract] [Full Text] [Related]
14. Prevention of post-transfusion graft-versus-host disease. Tasaki T; Ohto H; Abe R Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133 [TBL] [Abstract][Full Text] [Related]